Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy…

 

A new breakthrough in biomedical imaging allows surgeons to view the human liver in a 3D, full color hologram, helping the way they plan liver operations to remove tumors. The 3D hologram will allow oncologists and surgeons to “look around” the “virtual” organ. Until now, surgeons relied on 2D screens in order to view 3D information from MRI, CT and ultrasound scanning methods…

 

Cancer cells are well known for their altered metabolisms, which may help them generate the energy they need for rapid growth. Using an emerging imaging technology, researchers reporting in the July Cell Metabolism, a Cell Press publication, have discovered that those metabolic shifts actually develop even before detectable tumors form…

 

NICE has published a report on its pilot diagnostics project. The project, on the assessment of non-invasive diagnostic tests for the detection of liver fibrosis in patients with suspected alcohol related liver disease, was completed in December 2010…

 

Budd-Chiari syndrome (BCS) results from hepatic venous outflow obstruction at any level from hepatic venules to the right atrium. Few patients respond to medical treatment (anticoagulation with or without thrombolytic therapy, diuretics). However, most patients need intervention to restore the hepatic blood flow…

 

Osyris Medical, a leading laser medical company, announced that it has received clearance from the U.S. Food and Drug Administration for its LIPOCONTROL(TM) system for laser assisted lipolysis. The LipoControl is the latest generation of 980nm diode designed to be a workhorse in the operating room for laser assisted lipolysis…

 

EDDA Technology, a leading provider of advanced computer assisted radiology and surgery solutions, announces the successful commercial installation of its IQQA®-Liver Enterprise product at Mayo Clinic, Scottsdale, AZ…

 

In a research partnership between the Fraunhofer Institute for Medical Image Computing MEVIS in Bremen and the ARTORG Center for Biomedical Engineering Research at the University of Bern, this navigation technique will be intensively evaluated and developed further at the Eastern Hepatobiliary Surgery Hospital (EHBH) in Shanghai…

 

Delcath Systems, Inc. (Nasdaq: DCTH) announced that the Company has submitted its CE Mark Technical File to its European Notified Body to obtain CE Mark approval for its proprietary chemosaturation system, which the Company intends to market in the European Union (EU) as the Delcath Hepatic ChemoSAT™ Delivery System…

 

Growing groups of the so-called “worried well” are putting their lives at risk by shunning visits to their GP over alcoholic health related matters, according to new evidence…




May 2012
Mon Tue Wed Thu Fri Sat Sun
« Apr    
 123456
78910111213
14151617181920
21222324252627
28293031